Health product recall

STA – Liquid Anti-Xa

Last updated

Summary

Product
STA – Liquid Anti-Xa
Issue
Medical devices - Performance
What to do

Contact the manufacturer if you require additional information. 

Audience
Healthcare

Affected products

Affected products

Lot or serial number

Model or catalogue number

STA - Liquid Anti-Xa 4

All lots.

00311US

STA - Liquid Anti-Xa 8

All lots.

00322US

STA Satellite

All lots.

58104

STA - Fib 2, Sta - Fibrinogen 5

All lots.

00674

STA Satellite Max

All lots.

59004

Issue

Following internal tests, contamination of STA®-LIQUID ANTI-Xa by Stago Fibrinogen reagents was identified in UFH and LMWH applications on STA SATELLITE® or STA SATELLITE MAX® analyzers.  

Contamination occurs when one or more tests with the STA®-Fibrinogen 5 reagent are performed before the STA®-LIQUID ANTI-Xa test for heparin monitoring on an STA SATELLITE® or STA SATELLITE MAX® analyzer. This contamination causes an underestimation of heparin levels which could lead to a heparin treatment change and a subsequent overdose risk for the patient.

Recall start date: July 21, 2025

Additional information

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Medical devices - Haematology
Companies
Diagnostica Stago Sas
3 Allee Theresa, Asnieres Sur Seine, France, 92600
Published by
Health Canada
Audience
Healthcare
Recall class
Type II
Identification number
RA-77769

Get notified

Receive emails about new and updated recall and safety alerts.

Subscribe